YOLFTbeta
60

Zhongzhu Medical Holdings Co Ltd

600568 · SHG · Healthcare / Drug Manufacturers - Specialty & Generic

1.99CNY-0.01 (-0.50%)

Price History

Full chart

Market Stats

Previous Close2.00
Open2.02
Day Range1.98 – 2.02
52-Week Range1.76 – 3.27
Volume4.38M
Market Cap4.72B
P/E (TTM)0.00
Forward P/E40.49
EPS-0.07
Dividend Yield0.00%
Beta0.16
50-Day Avg2.26
200-Day Avg2.55

About

Zhongzhu Healthcare Holding Co.,Ltd engages in the research and development, production, and sale of drugs in China. The company offers Ophthalmic drugs, including pearl brightening eye drops, clindamycin phosphate for injection, acyclovir dispersible tablets, sodium cromoglycate eye drops, acyclovir for injection, diclofenac sodium suppositories, diclofenac sodium liniment, azithromycin granules, gatifloxacin for injection, mexorubicin suppositories, infusion heater, hyperthermia system, square meter products; and products related to tumor treatment. It is also involved in residential real estate development; property services; business operations; hospital management; and medical device sales and center cooperation. Zhongzhu Healthcare Holding Co.,Ltd was formerly known as Zhongzhu Holding Co., Ltd. and changed its name to Zhongzhu Healthcare Holding Co., Ltd in June 2016. The company was founded in 1970 and is headquartered in Zhuhai, China.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Pei Chao Si
  • Employees1.18K
  • HeadquartersYanlord Riviera Center, Zhuhai, China, 519020, China
  • Websitehttps://www.zz600568.com

Leadership

  • Mr. Pei Chao SiVice President · b. 1972
  • Mr. Hua MaPresident & Non-Independent Director · b. 1978
  • Xiaomin DengAccounting Supervisor
  • Yu Song ZhangBoard Secretary
  • Mr. Yu Cheng ZengVice President · b. 1990

Financials

Income Statement

Currency: CNY1998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue55.67M62.79M76.26M81.69M90.77M178.79M451.99M811.21M1.48B1.86B2.48B2.02B449.92M464.15M627.89M790.64M1.07B921.78M1.10B981.02M572.86M696.17M727.47M581.06M505.97M638.56M521.39M577.34M
Growth (%)-+12.78%+21.45%+7.12%+11.12%+96.97%+152.80%+79.47%+82.60%+25.58%+33.36%-18.50%-77.75%+3.16%+35.28%+25.92%+35.33%-13.85%+19.22%-10.73%-41.61%+21.53%+4.50%-20.13%-12.92%+26.21%-18.35%+10.73%
Cost of Revenue24.21M28.07M31.17M31.47M34.64M117.98M364.85M735.29M1.34B1.68B2.22B1.76B302.83M390.09M531.47M641.55M870.92M736.31M695.70M514.28M420.38M610.06M556.02M456.43M396.08M694.98M572.71M473.84M
Gross Profit31.46M34.72M45.09M50.22M56.13M60.81M87.14M75.92M138.26M184.22M259.19M266.73M147.09M74.06M96.42M149.09M199.06M185.47M403.27M466.74M152.48M86.11M171.45M124.63M109.89M-56.42M-51.32M103.50M
Gross Margin56.51%55.30%59.12%61.47%61.83%34.01%19.28%9.36%9.33%9.90%10.45%13.19%32.69%15.96%15.36%18.86%18.60%20.12%36.70%47.58%26.62%12.37%23.57%21.45%21.72%-8.84%-9.84%17.93%
Operating Expense19.69M21.20M25.84M29.07M37.43M47.77M74.85M106.93M189.56M114.30M154.19M64.43M80.47M-108.51M95.28M65.91M139.57M120.36M70.97M205.83M1.67B643.62M125.22M308.66M888.32M281.00M577.30M165.82M
Operating Income11.78M13.52M19.25M21.15M18.69M13.04M12.29M-31.02M-51.30M69.93M105.00M202.30M66.62M182.57M1.14M83.18M59.49M65.11M332.30M260.91M-1.52B-557.51M46.23M-184.03M-778.43M-337.42M-628.62M-62.32M
Operating Margin21.15%21.53%25.25%25.89%20.60%7.29%2.72%-3.82%-3.46%3.76%4.23%10.01%14.81%39.33%0.18%10.52%5.56%7.06%30.24%26.60%-265.44%-80.08%6.36%-31.67%-153.85%-52.84%-120.57%-10.79%
EBITDA13.11M17.40M23.96M25.61M14.45M14.84M27.49M3.33M-3.25M129.68M157.78M159.10M105.04M215.16M115.31M122.96M105.61M141.84M479.44M341.67M-1.82B-296.90M130.31M-93.99M-708.77M-264.26M-562.15M-58.96M
EBITDA Margin23.54%27.70%31.42%31.36%15.92%8.30%6.08%0.41%-0.22%6.97%6.36%7.87%23.35%46.36%18.36%15.55%9.87%15.39%43.63%34.83%-318.19%-42.65%17.91%-16.17%-140.08%-41.38%-107.82%-10.21%
Net Income9.56M11.07M12.61M13.87M11.19M11.57M8.76M-37.93M-86.62M18.44M40.97M146.55M73.77M183.06M60.23M60.63M32.41M73.41M294.17M169.34M-1.89B-369.50M3.22M-211.28M-799.26M-343.94M-620.22M-114.19M
Net Income Margin17.17%17.64%16.53%16.98%12.33%6.47%1.94%-4.68%-5.85%0.99%1.65%7.25%16.40%39.44%9.59%7.67%3.03%7.96%26.77%17.26%-330.73%-53.08%0.44%-36.36%-157.97%-53.86%-118.96%-19.78%
R&D--------------6.84M5.30M4.77M7.13M35.38M13.76M55.46M61.28M23.44M24.68M18.21M16.18M11.96M12.16M
R&D as % of Total Revenue--------------1.09%0.67%0.45%0.77%3.22%1.40%9.68%8.80%3.22%4.25%3.60%2.53%2.29%2.11%
Interest Expense1.33M951.21K1.39M458.69K31.89K57.31K2.62M6.65M16.56M18.39M28.21M8.28M10.11M16.54M30.14M36.38M37.16M28.51M35.87M10.89M13.27M8.57M5.35M16.32M15.41M7.72M1.08M664.12K
Interest Expense % of Total Revenue2.39%1.51%1.82%0.56%0.04%0.03%0.58%0.82%1.12%0.99%1.14%0.41%2.25%3.56%4.80%4.60%3.47%3.09%3.26%1.11%2.32%1.23%0.74%2.81%3.05%1.21%0.21%0.12%

Balance Sheet

Currency: CNY1998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets104.47M114.25M134.37M460.31M478.20M569.42M771.64M1.38B1.31B1.33B1.66B1.43B2.12B2.10B2.25B2.64B4.54B4.29B7.14B7.27B5.62B4.78B4.53B4.46B3.71B3.02B2.12B1.97B
Total Liabilities45.79M44.49M52.00M26.84M33.54M96.51M282.16M824.06M828.56M813.71M1.05B755.02M1.38B1.18B1.23B1.46B1.96B1.65B1.13B1.13B1.36B888.46M545.44M729.24M775.97M428.35M377.87M343.56M
Total Equity58.68M69.76M82.36M433.47M444.66M456.32M473.79M443.99M356.47M368.17M413.97M643.23M728.87M911.93M968.00M1.03B2.37B2.44B5.86B5.99B4.05B3.69B3.80B3.60B2.80B2.45B1.75B1.64B
Cash5.84M9.47M10.40M119.68M218.64M59.93M72.60M109.63M107.91M58.51M188.15M117.63M191.95M137.92M250.72M328.47M1.48B528.47M1.69B1.77B1.03B604.93M698.61M527.35M577.18M533.98M403.74M389.13M
Total Debt10.50M15.50M30.00M---100.00M237.10M258.65M265.00M316.86M280.80M546.60M581.40M603.01M717.70M1.01B755.52M278.69M374.41M268.72M135.68M37.00M283.90M273.02M15.43M16.41M-
Net Debt4.66M6.03M19.60M-119.68M-218.64M-59.93M27.40M127.47M150.74M206.49M128.72M163.17M354.65M443.48M352.29M389.23M-473.00M227.05M-1.42B-1.40B-759.30M-469.25M-661.61M-243.45M-304.17M-518.55M-391.66M-

Cash Flow

Currency: CNY1999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow6.72M2.85M4.59M566.66K551.80K2.75M57.27M48.49M3.58M90.74M-253.20M-531.24M-74.80M-48.43M3.56M14.34M189.05M296.58M-358.29M-267.76M614.57M248.15M94.04M25.52M2.77M32.63M56.08M
Investing Cash Flow-7.53M-12.27M-216.23M98.39M-171.98M-88.27M-28.40M-36.61M-19.21M-18.03M-54.23M241.89M-5.49M-62.16M-64.85M-233.05M-680.89M136.73M249.96M-518.80M-822.51M157.68M-154.04M-121.86M-41.22M60.28M-
Financing Cash Flow4.45M10.34M320.93M-2.77M98.20M-13.81M27.54M-33.77M56.93M233.16M363.68M-14.25M180.57M133.45M1.44B-393.94M709.39M183.55M-166.89M-171.13M-116.26M-107.17M-37.09M-11.49M-121.17M-
Capital Expenditure7.53M12.36M16.90M93.49M174.83M55.39M11.18M17.71M19.50M17.69M8.79M12.32M3.00M6.23M92.54M122.07M76.17M111.49M55.74M169.29M765.63M99.71M63.00M25.95M27.26M12.82M32.08M
Free Cash Flow-811.57K-9.52M-12.31M-92.92M-174.28M-52.64M46.09M30.78M-15.92M73.05M-262.00M-543.55M-77.80M-54.66M-88.98M-107.73M112.87M185.09M-414.03M-437.06M-151.06M148.45M31.04M-429.31K-24.49M19.81M24.00M
Dividends Paid951.21K1.83M458.69K--2.30M6.81M15.68M21.46M25.76M10.24M10.76M40.70M53.22M58.54M71.09M92.79M59.68M47.17M59.60M11.23M4.41M1.12M105.63K102.97K324.38K32.96K
FCF to OCF-12.09%-334.10%-268.50%-16398.09%-31584.00%-1916.41%80.48%63.48%-445.38%80.51%103.47%102.32%104.02%112.86%-2501.93%-751.37%59.71%62.41%115.56%163.22%-24.58%59.82%33.01%-1.68%-883.53%60.71%42.79%
Dividend Paid to FCF-117.21%-19.21%-3.73%---4.37%14.78%50.93%-134.77%35.26%-3.91%-1.98%-52.31%-97.37%-65.79%-65.99%82.21%32.24%-11.39%-13.64%-7.44%2.97%3.60%-24.60%-0.42%1.64%0.14%

Earnings

Report DateMar 31, 2010Jun 30, 2010Sep 30, 2010Dec 31, 2010Mar 31, 2011Jun 30, 2011Sep 30, 2011Dec 31, 2011Mar 31, 2012Jun 30, 2012Sep 30, 2012Dec 31, 2012Mar 31, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013Mar 31, 2014Jun 30, 2014Oct 31, 2014Mar 19, 2015Apr 30, 2015Aug 29, 2015Oct 31, 2015Dec 31, 2015Apr 16, 2016Aug 31, 2016Oct 28, 2016Dec 31, 2016Apr 29, 2017Aug 31, 2017Oct 30, 2017Dec 31, 2017Apr 28, 2018Jun 30, 2018Sep 30, 2018Dec 31, 2018Mar 31, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Mar 31, 2020Aug 29, 2020Oct 28, 2020Dec 31, 2020Apr 30, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023
EPS Estimate-----------------------------------------------------
EPS Actual-0.010.030.05-0.000.010.010.17-0.010.000.030.020.000.020.030.010.010.02-0.01-0.010.030.010.030.000.010.020.050.020.060.030.060.04-0.040.03-0.00-0.02-0.96-0.010.01-0.02-0.17-0.01-0.00-0.010.02-0.01-0.01-0.01-0.07-0.00-0.01-0.01-0.38-0.01
Surprise-----------------------------------------------------
Timing------------------Pre-marketAfter-hoursPre-marketAfter-hoursPre-market-Pre-marketPre-marketAfter-hours-Pre-marketPre-marketPre-market-Pre-market--------------------

Key Statistics & Ratios

Market Cap4.72B
Enterprise Value4.34B
Trailing P/E0.00
Forward P/E40.49
Price / Sales8.85
Price / Book2.96
EPS-0.07
Book Value0.825
Revenue (TTM)533.88M
Gross Profit (TTM)61.00M
EBITDA-35.48M
Profit Margin-24.78%
Operating Margin-15.74%
Return on Equity-8.32%
Return on Assets-2.93%
Shares Outstanding1.99B
Shares Float847.25M
Beta0.16
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20181×
0.02Aug 7, 2018
20171×
0.05Jul 13, 2017
20161×
0.01Jun 3, 2016
20151×
0.01Jun 11, 2015
20121×
0.01Nov 12, 2012
20061×
0.23Aug 9, 2006

Stock Splits

  • Jul 13, 201783429:29796
  • Nov 12, 2012196106:89139
  • Jul 8, 20043:2